233 related articles for article (PubMed ID: 3079801)
1. Modulation of the population density of identifiable epidermal Langerhans cells associated with enhancement or suppression of cutaneous immune reactivity.
Rheins LA; Nordlund JJ
J Immunol; 1986 Feb; 136(3):867-76. PubMed ID: 3079801
[TBL] [Abstract][Full Text] [Related]
2. Correlation between keratinocyte expression of Ia and the intensity and duration of contact hypersensitivity responses in mice.
Roberts LK; Spangrude GJ; Daynes RA; Krueger GG
J Immunol; 1985 Nov; 135(5):2929-36. PubMed ID: 3862711
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB.
Toews GB; Bergstresser PR; Streilein JW
J Immunol; 1980 Jan; 124(1):445-53. PubMed ID: 6153101
[No Abstract] [Full Text] [Related]
4. Relationship between epidermal Langerhans cell density ATPase activity and the induction of contact hypersensitivity.
Lynch DH; Gurish MF; Daynes RA
J Immunol; 1981 May; 126(5):1892-7. PubMed ID: 6452479
[TBL] [Abstract][Full Text] [Related]
5. Rapid induction of Thy-1 antigenic markers on keratinocytes and epidermal immune cells in the skin of mice following topical treatment with common preservatives used in topical medications and in foods.
Rheins LA; Young EM; Nordlund ML; Berning RB; Nordlund JJ
J Invest Dermatol; 1987 Nov; 89(5):489-94. PubMed ID: 2889782
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity.
Girolomoni G; Pastore S; Zacchi V; Cavani A; Marconi A; Giannetti A
J Immunol; 1993 May; 150(10):4236-43. PubMed ID: 8482834
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of systemic immune suppression by UV irradiation in vivo. II. The UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies.
Noonan FP; Bucana C; Sauder DN; De Fabo EC
J Immunol; 1984 May; 132(5):2408-16. PubMed ID: 6232317
[TBL] [Abstract][Full Text] [Related]
8. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
[TBL] [Abstract][Full Text] [Related]
9. High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity.
Bacci S; Alard P; Dai R; Nakamura T; Streilein JW
Eur J Immunol; 1997 Feb; 27(2):442-8. PubMed ID: 9045915
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis.
Halliday GM; Lucas AD
Immunology; 1993 Aug; 79(4):621-6. PubMed ID: 8406587
[TBL] [Abstract][Full Text] [Related]
11. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
12. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultraviolet-exposed epidermal cells is dependent upon infiltrating class II MHC+ CD11bbright monocytic/macrophagic cells.
Hammerberg C; Duraiswamy N; Cooper KD
J Immunol; 1994 Dec; 153(11):4915-24. PubMed ID: 7963554
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the cutaneous immune response following topical application of the prostaglandin PGE2.
Rheins LA; Barnes L; Amornsiripanitch S; Collins CE; Nordlund JJ
Cell Immunol; 1987 Apr; 106(1):33-42. PubMed ID: 2952282
[TBL] [Abstract][Full Text] [Related]
14. Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells.
Aberer W; Romani N; Elbe A; Stingl G
J Immunol; 1986 Feb; 136(4):1210-6. PubMed ID: 2868057
[TBL] [Abstract][Full Text] [Related]
15. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
[TBL] [Abstract][Full Text] [Related]
16. Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies.
Ray MC; Tharp MD; Sullivan TJ; Tigelaar RE
J Immunol; 1983 Sep; 131(3):1096-102. PubMed ID: 6193174
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the contact hypersensitivity response following topical exposure to 2-butoxyethanol in female BALB/c mice.
Singh P; Morris B; Zhao S; Blaylock BL
Int J Toxicol; 2002; 21(2):107-14. PubMed ID: 12022630
[TBL] [Abstract][Full Text] [Related]
18. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
Aberer W; Kruisbeek AM; Shimada S; Katz SI
J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
[TBL] [Abstract][Full Text] [Related]
19. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice.
Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN
J Immunol; 1999 Jan; 162(1):277-83. PubMed ID: 9886396
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.
Suzuki H; Wang B; Shivji GM; Toto P; Amerio P; Tomai MA; Miller RL; Sauder DN
J Invest Dermatol; 2000 Jan; 114(1):135-41. PubMed ID: 10620129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
